Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bard

This article was originally published in The Gray Sheet

Executive Summary

Appoints Gerald Messerschmidt, MD, to the newly created post of vice president, scientific affairs. Messerschmidt, 43, will have company-wide responsibility for "medical and clinical affairs, regulatory affairs, quality assurance and environmental health and safety," the firm states in a Jan. 12 announcement. Bard agreed to create such a post under a deal reached in October settling numerous criminal and civil charges related to the firm's USCI angioplasty operations ("The Gray Sheet" Oct. 18, p. 3). The new exec, who will answer to President and Chief Operating Officer William Longfield, most recently served as VP, medical and regulatory affairs at Princeton-based DNX Corp
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel